Abstract

Date Presented Accepted for AOTA INSPIRE 2021 but unable to be presented due to online event limitations.

Cancer-related cognitive decline (CRCD) is not well understood in the oncology population, and evaluation for cognitive dysfunction while inpatient is not routine. The aims of this project are to (1) identify the prevalence of CRCD in an inpatient hospital, utilizing the Trail Making Test Part B, and (2) identify differences between individuals experiencing CRCD and those scoring within normal limits.

Primary Author and Speaker: Erika Dobson

Additional Authors and Speakers: Malarie Chant

You do not currently have access to this content.